{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:40:02Z","timestamp":1773279602318,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009125","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000}}],"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Melioidosis, caused by the Gram-negative bacterium <jats:italic>Burkholderia pseudomallei<\/jats:italic>, is a major cause of sepsis and mortality in endemic regions of Southeast Asia and Northern Australia. <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> is a potential bioterrorism agent due to its high infectivity, especially via inhalation, and its inherent resistance to antimicrobials. There is currently no vaccine for melioidosis and antibiotic treatment can fail due to innate drug resistance, delayed diagnosis and treatment, or insufficient duration of treatment. A well-characterized animal model that mimics human melioidosis is needed for the development of new medical countermeasures. This study first characterized the disease progression of melioidosis in the African green monkey (AGM) and rhesus macaque (RM) for non-human primate model down-selection. All AGMs developed acute lethal disease similar to that described in human acute infection following exposure to aerosolized <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> strain HBPUB10134a. Only 20% of RMs succumbed to acute disease. Disease progression, immune response and pathology of two other strains of <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic>, K96243 and MSHR5855, were also compared using AGMs. These three <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> strains represent a highly virulent strain from Thailand (HBPUB101034a), a highly virulent strains from Australia (MSHR5855), and a commonly used laboratory strains originating from Thailand (K96243). Animals were observed for clinical signs of infection and blood samples were analyzed for cytokine responses, blood chemistry and leukocyte changes in order to characterize bacterial infection. AGMs experienced fever after exposure to aerosolized <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> at the onset of acute disease. Inflammation, abscesses and\/or pyogranulomas were observed in lung with all three strains of <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic>. Inflammation, abscesses and\/or pyogranulomas were observed in lymph nodes, spleen, liver and\/or kidney with <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic>, HBPUB10134a and K96243. Additionally, the Australian strain MSHR5855 induced brain lesions in one AGM similar to clinical cases of melioidosis seen in Australia. Elevated serum levels of IL-1\u03b2, IL-1 receptor antagonist, IL-6, MCP-1, G-CSF, HGF, IFN\u03b3, MIG, I-TAC, and MIP-1\u03b2 at terminal end points can be significantly correlated with non-survivors with <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> infection in AGM. The AGM model represents an acute model of <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> infection for all three strains from two geographical locations and will be useful for efficacy testing of vaccines and therapeutics against melioidosis. In summary, a dysregulated immune response leading to excessive persistent inflammation and inflammatory cell death is the key driver of acute melioidosis. Early intervention in these pathways will be necessary to counter <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> and mitigate the pathological consequences of melioidosis.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009125","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T19:40:43Z","timestamp":1613158843000},"page":"e0009125","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6589-8198","authenticated-orcid":true,"given":"Sylvia R.","family":"Trevino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Dankmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Fetterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Klimko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-9062","authenticated-orcid":true,"given":"Jo Lynne W.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia M.","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-4235","authenticated-orcid":true,"given":"Carl","family":"Soffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Waag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia L.","family":"Worsham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Amemiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1134-6405","authenticated-orcid":true,"given":"Sara I.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7110-1197","authenticated-orcid":true,"given":"Teresa","family":"Krakauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"issue":"1","key":"pntd.0009125.ref001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment","volume":"36","author":"BJ Currie","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"pntd.0009125.ref002","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis","volume":"4","author":"WJ Wiersinga","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"pntd.0009125.ref003","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis","volume":"367","author":"WJ Wiersinga","year":"2012","journal-title":"N Engl J Med"},{"key":"pntd.0009125.ref004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"WJ Wiersinga","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"pntd.0009125.ref005","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1128\/AEM.01036-06","article-title":"Enviromental factors that affect the survival and persistence of Burkholderia pseudomallei","volume":"72","author":"TJJ Inglis","year":"2006","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"pntd.0009125.ref006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"AC Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"pntd.0009125.ref007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/CMR.4.1.52","article-title":"Melioidosis: the tip of the iceberg?","volume":"4","author":"DA Dance","year":"1991","journal-title":"Clin Microbiol Rev"},{"issue":"2\u20133","key":"pntd.0009125.ref008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0001-706X(99)00059-5","article-title":"Melioidosis as an emerging global problem","volume":"74","author":"DA Dance","year":"2000","journal-title":"Acta Trop"},{"issue":"10","key":"pntd.0009125.ref009","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3201\/eid1510.090246","article-title":"Melioidosis in a tropical city state, Singapore","volume":"15","author":"TJ Lo","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009125.ref010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2334-11-126","article-title":"Pulmonary melioidosis in Cambodia: a prospective study","volume":"11","author":"B Rammaert","year":"2011","journal-title":"BMC Infect Dis"},{"key":"pntd.0009125.ref011","first-page":"147","volume-title":"Textbook of Military Medicine: Medical aspects of Biological Warfare","author":"NJ Vietri","year":"1997"},{"issue":"12","key":"pntd.0009125.ref012","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3201\/eid0912.020750","article-title":"Intensity of rainfall and severity of melioidosis, Australia","volume":"9","author":"BJ Currie","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009125.ref013","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2334-10-302","article-title":"Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia","volume":"10","author":"MR Hassan","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pntd.0009125.ref014","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3201\/eid2101.140042","article-title":"Association of melioidosis incidence with rainfall and humidity, singapore, 2003\u20132012","volume":"21","author":"X Liu","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"pntd.0009125.ref015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1086\/520223","article-title":"Risk factors for melioidosis and bacteremic melioidosis","volume":"29","author":"Y Suputtamongkol","year":"1999","journal-title":"Clin Infect Dis"},{"key":"pntd.0009125.ref016","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis.","volume":"43","author":"D Dance","year":"2014","journal-title":"Intern J Antimicrob Agents"},{"issue":"2","key":"pntd.0009125.ref017","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3201\/eid0802.010164","article-title":"Public health assessment of potential biological terrorism agents","volume":"8","author":"LD Rotz","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009125.ref018","unstructured":"Bolivar P. Tier 1 select agents and toxins of bioterrorism, May 2013. pattphdepi:27.files.wordpress.com"},{"key":"pntd.0009125.ref019","article-title":"Burkholderia pseudomallei and Burkholderia mallei vaccines: are we close to clinical trials? Vaccine. 2017; 35:5981\u20135989.","author":"RW Titball"},{"issue":"6","key":"pntd.0009125.ref020","doi-asserted-by":"crossref","first-page":"e141480","DOI":"10.3201\/eid2106.141480","article-title":"Steering Group on Melioidosis Vaccine Development. Consensus on the development of vaccines against naturally acquired melioidosis","volume":"21","author":"D Limmathurotsakul","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009125.ref021","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.micro.112408.134030","article-title":"Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis","volume":"64","author":"EE Galyov","year":"2009","journal-title":"Annu Rev Microbiol"},{"issue":"9","key":"pntd.0009125.ref022","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1586\/14760584.7.9.1357","article-title":"Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei","volume":"7","author":"SK Bondi","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"pntd.0009125.ref023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/mpat.1997.0179","article-title":"BALB\/c and C57Bl\/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis","volume":"24","author":"AK Leakey","year":"1998","journal-title":"Microb Pathog"},{"issue":"4","key":"pntd.0009125.ref024","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1128\/IAI.68.4.2034-2042.2000","article-title":"Cytokine gene expression in innately susceptible BALB\/c mice and relatively resistant C57BL\/6 mice during infection with virulent Burkholderia pseudomallei","volume":"68","author":"GC Ulett","year":"2000","journal-title":"Infect Immun"},{"issue":"Suppl 1","key":"pntd.0009125.ref025","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0035-9203(08)70026-9","article-title":"Burkholderia pseudomallei: animal models of infection","volume":"102","author":"RW Titball","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009125.ref026","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1099\/jmm.0.47596-0","article-title":"Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB\/c and C57Bl\/6 mice","volume":"57","author":"GY Tan","year":"2008","journal-title":"J Med Microbiol"},{"key":"pntd.0009125.ref027","doi-asserted-by":"crossref","first-page":"e0124667","DOI":"10.1371\/journal.pone.0124667","article-title":"Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays","volume":"10","author":"SL Welkos","year":"2015","journal-title":"PLoS One"},{"key":"pntd.0009125.ref028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.micpath.2015.07.004","article-title":"Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB\/c mice","volume":"86","author":"K Amemiya","year":"2015","journal-title":"Microb Pathog"},{"issue":"2","key":"pntd.0009125.ref029","doi-asserted-by":"crossref","first-page":"e0172627","DOI":"10.1371\/journal.pone.0172627","article-title":"Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB\/c and C57BL\/6 mice","volume":"12","author":"JJ Bearss","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"pntd.0009125.ref030","doi-asserted-by":"crossref","first-page":"e0208277","DOI":"10.1371\/journal.pone.0208277","article-title":"Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei","volume":"13","author":"SR Trevino","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"pntd.0009125.ref031","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/IAI.00737-06","article-title":"Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis","volume":"74","author":"A Tuanyok","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"pntd.0009125.ref032","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.femsle.2004.10.045","article-title":"Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model","volume":"242","author":"J Warawa","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"pntd.0009125.ref033","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/S0264-410X(02)00119-6","article-title":"Determination of the virulence of the pigmentation-deficient and pigmentation-\/ plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague","volume":"20","author":"S Welkos","year":"2002","journal-title":"Vaccine"},{"issue":"11","key":"pntd.0009125.ref034","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/CVI.00288-12","article-title":"Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques","volume":"19","author":"LN Henning","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"pntd.0009125.ref035","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1128\/IAI.00675-12","article-title":"Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops)","volume":"80","author":"JJ Yeager","year":"2012","journal-title":"Infect Immun"},{"issue":"Pt 1","key":"pntd.0009125.ref036","article-title":"Pathological findings and diagnostic implications of a rhesus macaque (Macaca mulatta) model of aerosol-exposure melioidosis (Burkholderia pseudomallei)","volume":"63","author":"SL Yingst","year":"2014","journal-title":"J Med Microbiol"},{"issue":"6","key":"pntd.0009125.ref037","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2613.2011.00791.x","article-title":"Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus)","volume":"92","author":"M Nelson","year":"2011","journal-title":"Int J Exp Pathol"},{"issue":"3","key":"pntd.0009125.ref038","doi-asserted-by":"crossref","first-page":"e0121052","DOI":"10.1371\/journal.pone.0121052","article-title":"Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: comparative genomics associated with differential virulence","volume":"10","author":"JW Sahl","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"pntd.0009125.ref039","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/iep.12161","article-title":"Characterization of lesion formation in marmosets following inhalational challenge with different strains of Burkholderia pseudomallei","volume":"96","author":"M Nelson","year":"2015","journal-title":"Int J Exp Pathol"},{"key":"pntd.0009125.ref040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fcimb.2012.00120","article-title":"An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing","volume":"2","author":"KE Van Zandt","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"pntd.0009125.ref041","first-page":"S423","article-title":"Tumor necrosis factor in the pathogenesis of infectious diseases.","volume":"21","author":"B Beutler","year":"1993","journal-title":"Crit Care Med"},{"issue":"6","key":"pntd.0009125.ref042","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/IAI.01733-06","article-title":"High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei","volume":"75","author":"WJ Wiersinga","year":"2007","journal-title":"Infect Immun"},{"key":"pntd.0009125.ref043","doi-asserted-by":"crossref","first-page":"e00006","DOI":"10.1128\/CMR.00006-19","article-title":"Human melioidosis","volume":"33","author":"I Gassiep","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0009125.ref044","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1189\/jlb.0809549","article-title":"When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system","volume":"87","author":"MT Silva","year":"2010","journal-title":"J Leuko Biol"},{"key":"pntd.0009125.ref045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1099\/00222615-31-2-109","article-title":"Survival of Pseudomonas pseudomallei in human phagocytes","volume":"31","author":"S Pruksachartvuthi","year":"1999","journal-title":"J Med Microbiol"},{"key":"pntd.0009125.ref046","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00281-013-0374-8","article-title":"Neutrophils in innate and adaptive immunity","volume":"35","author":"S Jaillon","year":"2013","journal-title":"Semin Immunopathol"},{"key":"pntd.0009125.ref047","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"E Kolaczkowska","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"pntd.0009125.ref048","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMra074111","article-title":"Acute lower respiratory tract infection","volume":"358","author":"JP Mizgerd","year":"2008","journal-title":"N Engl J Med"},{"key":"pntd.0009125.ref049","first-page":"775","volume-title":"Fundamental Immunology","author":"T Krakauer","year":"1998","edition":"4"},{"issue":"4","key":"pntd.0009125.ref050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1165\/ajrcmb\/2.4.321","article-title":"Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta","volume":"2","author":"RM Strieter","year":"1990","journal-title":"Am J Respir Cell Mol Biol"},{"key":"pntd.0009125.ref051","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri3600","article-title":"Alveolar macrophages: plasticity in a tissue-specific context","volume":"14","author":"T Hussell","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"pntd.0009125.ref052","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"T Kawai","year":"2011","journal-title":"Immunity"},{"key":"pntd.0009125.ref053","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.immuni.2010.03.012","article-title":"Intracellular toll-like receptors","volume":"32","author":"A. L. Blasius","year":"2010","journal-title":"Immunity"},{"key":"pntd.0009125.ref054","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2008.06.001","article-title":"NOD-like receptors (NLRs): bona fide intracellular microbial sensors","volume":"20","author":"MH Shaw","year":"2008","journal-title":"Curr Opinion Immunol"},{"key":"pntd.0009125.ref055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"E Latz","year":"2013","journal-title":"Nature Rev Immunol"},{"key":"pntd.0009125.ref056","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"VAK Rathinam","year":"2016","journal-title":"Cell"},{"key":"pntd.0009125.ref057","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coi.2015.01.010","article-title":"The NAIP\/NLRC4 inflammasomes","volume":"32","author":"R. E. Vance","year":"2015","journal-title":"Curr Opinion Immunol"},{"issue":"1","key":"pntd.0009125.ref058","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4049\/jimmunol.1301436","article-title":"The role of NOD2 in murine and human melioidosis","volume":"192","author":"ND Myers","year":"2014","journal-title":"J Immunol"},{"key":"pntd.0009125.ref059","doi-asserted-by":"crossref","first-page":"e3178","DOI":"10.1371\/journal.pntd.0003178","article-title":"NLRC4 and TLR5 Each Contribute to Host Defense in Respiratory Melioidosis","volume":"8","author":"TE West","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0009125.ref060","doi-asserted-by":"crossref","first-page":"e1003986","DOI":"10.1371\/journal.ppat.1003986","article-title":"Caspase-1-dependent and -independent cell death pathways in Burkholderia pseudomallei infection of macrophages","volume":"10","author":"A Bast","year":"2014","journal-title":"PLoS Pathog"},{"key":"pntd.0009125.ref061","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-induced pyroptotic cell death","volume":"243","author":"EA Miao","year":"2011","journal-title":"Immunol Rev"},{"key":"pntd.0009125.ref062","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-065X.2008.00701.x","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: 10 years of progress","volume":"226","author":"LA O\u2019Neill","year":"2008","journal-title":"Immunol Rev"},{"issue":"4","key":"pntd.0009125.ref063","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and Related Cytokines in the regulation of inflammation and immunity","volume":"50","author":"A Mantovani","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"pntd.0009125.ref064","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/IAI.67.7.3593-3600.1999","article-title":"Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei","volume":"67","author":"P Santanirand","year":"1999","journal-title":"Infect Immun"},{"key":"pntd.0009125.ref065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"A Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"pntd.0009125.ref066","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-006-0019-9","article-title":"Interleukin-6 and its receptor: from bench to bedside","volume":"195","author":"J Scheller","year":"2006","journal-title":"Med Microbiol Immunol"},{"key":"pntd.0009125.ref067","first-page":"2591","article-title":"IL-6 antagonizes TGF-\u03b2 and abolishes immune privilege in eyes with endotoxin-induced uveitis","volume":"41","author":"K Ohta","year":"2000","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"pntd.0009125.ref068","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/373699a0","article-title":"Scatter factor\/hepatocyte growth factor is essential for liver development","volume":"373","author":"C Schmidt","year":"1995","journal-title":"Nature"},{"issue":"3","key":"pntd.0009125.ref069","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cyto.2008.03.002","article-title":"Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and \u2019emergency\u2019 hematopoiesis","volume":"42","author":"AD Panopoulos","year":"2008","journal-title":"Cytokine"},{"issue":"4","key":"pntd.0009125.ref070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 Family Cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"W Ouyang","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"pntd.0009125.ref071","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/IAI.60.6.2402-2408.1992","article-title":"Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection","volume":"60","author":"JS Friedland","year":"1992","journal-title":"Infect Immun"},{"issue":"2","key":"pntd.0009125.ref072","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1086\/315271","article-title":"Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis","volume":"181","author":"AJ Simpson","year":"2000","journal-title":"J Infect Dis"},{"issue":"6","key":"pntd.0009125.ref073","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1086\/315155","article-title":"Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis","volume":"180","author":"FN Lauw","year":"1999","journal-title":"J Infect Dis"},{"key":"pntd.0009125.ref074","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2010.06.007","article-title":"Manipulation of host cell death pathways during microbial infections","volume":"8","author":"M Lamkanfi","year":"2010","journal-title":"Cell Host Microbe"},{"key":"pntd.0009125.ref075","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells","volume":"73","author":"SL Fink","year":"2005","journal-title":"Infect Immun"},{"key":"pntd.0009125.ref076","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mehy.2018.09.028","article-title":"Living dangerously: Burkholderia pseudomallei modulates phagocyte cell death to survive","volume":"121","author":"T. Krakauer","year":"2018","journal-title":"Med Hypothesis"},{"key":"pntd.0009125.ref077","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/B:APPT.0000031448.64969.fa","article-title":"Modulation of phagocyte apoptosis by bacterial pathogens","volume":"9","author":"FR DeLeo","year":"2004","journal-title":"Apoptosis"},{"key":"pntd.0009125.ref078","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mib.2013.10.007","article-title":"Macrophages clean up: efferocytosis and microbial control","volume":"17","author":"CJ Martin","year":"2014","journal-title":"Curr Opin Microbiol"},{"key":"pntd.0009125.ref079","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","article-title":"Cell removal: Efferocytosis","volume":"33","author":"PM Henson","year":"2017","journal-title":"Ann Rev Cell Dev Biol"},{"key":"pntd.0009125.ref080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF","volume":"101","author":"VA Fadok","year":"1998","journal-title":"J Clin Invest"},{"issue":"1","key":"pntd.0009125.ref081","doi-asserted-by":"crossref","first-page":"e54961","DOI":"10.1371\/journal.pone.0054961","article-title":"Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling","volume":"8","author":"GC Koh","year":"2013","journal-title":"PLoS One"},{"key":"pntd.0009125.ref082","doi-asserted-by":"crossref","first-page":"e2988","DOI":"10.1371\/journal.pntd.0002988","article-title":"Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages","volume":"8","author":"M Mulye","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009125.ref083","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1128\/IAI.00966-06","article-title":"Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice","volume":"74","author":"K Breitbach","year":"2006","journal-title":"Infect Immun"},{"key":"pntd.0009125.ref084","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/509810","article-title":"A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei","volume":"195","author":"A Easton","year":"2007","journal-title":"J Infect Dis"},{"key":"pntd.0009125.ref085","first-page":"170","volume":"2","author":"EM Allwood","year":"2011","journal-title":"Strategies for"},{"key":"pntd.0009125.ref086","doi-asserted-by":"crossref","first-page":"e0005571","DOI":"10.1371\/journal.pntd.0005571","article-title":"Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling","volume":"11","author":"MH Norris","year":"2017","journal-title":"Tuanyok.PLoS Negl Trop Dis"},{"issue":"7","key":"pntd.0009125.ref087","doi-asserted-by":"crossref","first-page":"e0007369","DOI":"10.1371\/journal.pntd.0007369","article-title":"Tracing the environmental footprint of the Burkholderia pseudomallei lipopolysaccharide genotypes in the tropical \"Top End\" of the Northern Territory, Australia","volume":"13","author":"JR Webb","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0009125.ref088","first-page":"e91682","article-title":"Variable Virulence Factors in Burkholderia pseudomallei (Melioidosis) Associated with Human DiseasePLoS One","volume":"9","author":"DS Sarovich","year":"2014"},{"issue":"24","key":"pntd.0009125.ref089","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1128\/JB.01264-07","article-title":"A horizontal gene transfer event defines two distinct groups within Burkholderia pseudomallei that have dissimilar geographic distributions","volume":"189","author":"A Tuanyok","year":"2007","journal-title":"J Bacteriol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009125","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T18:49:31Z","timestamp":1614192571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009125"}},"subtitle":[],"editor":[{"given":"Alfredo G.","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":89,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009125","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009125","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]}}}